Radius Health, a developer of drugs for treating osteoporosis and other women's health...

|By:, SA News Editor

Radius Health, a developer of drugs for treating osteoporosis and other women's health conditions, is filing for an $86.3M IPO under the ticker RDUS. Radius, whose four drug candidates are all in development stage, had no revenue in 2011, and a net loss of $42.5M.